Management of hypertension in peripheral arterial disease: Does the choice of drugs matter?

被引:45
作者
Singer, D. R. J. [2 ]
Kite, A. [1 ]
机构
[1] Univ Hosp, Coventry CV2 2DX, W Midlands, England
[2] Univ Warwick, Clin Sci Res Inst, Warwick Med Sch, Coventry CV2 2DX, W Midlands, England
关键词
atheromatous peripheral artery disease; hypertension; cardiovascular risk;
D O I
10.1016/j.ejvs.2008.01.007
中图分类号
R61 [外科手术学];
学科分类号
摘要
Cardiovascular disease and death are major life-threatening problems in patients with atheromatous peripheral arterial disease (PAD). This review focuses on management of hypertension in the context Of cardiovascular risk in patients with PAD. PAD is underdiagnosed and hypertension in PAD is often poorly managed. Current evidence supports a low threshold for blood pressure treatment in PAD and intensive blood pressure control to reduce the high risk of cardiovascular disease and death in patients with PAD. Optimal treatment targets should be < 140185 mmHg, with the lower target of < 130/80 mmHg in the presence of diabetes mellitus or chronic renal disease. Class-specific selection of anti-hypertensive treatments in PAD should be based on caution in relation to co-existing renovascular disease and indications and contraindications based on other significant co-morbidity. There is a pressing need for primary end-point studies targeted specifically at patients with PAD. In particular, prospective studies in PAD are needed to obtain evidence for benefits from specific blood pressure classes of treatment as well as the optimal blood pressure treatment target level. These studies should consider impact in PAD of different demographic, risk factor, and co-morbidity profiles. (c) 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:701 / 708
页数:8
相关论文
共 38 条
  • [1] [Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.1997.00440420033005
  • [2] Diabetes and atherosclerosis - Epidemiology, pathophysiology, and management
    Beckman, JA
    Creager, MA
    Libby, P
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (19): : 2570 - 2581
  • [3] *BRIT HYP SOC, 2007, CG34 HYP MAN AD PRIM
  • [4] Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)
    Brown, MJ
    Palmer, CR
    Castaigne, A
    de Leeuw, PW
    Mancia, G
    Rosenthal, T
    Ruilope, LM
    [J]. LANCET, 2000, 356 (9227) : 366 - 372
  • [5] BLOOD-PRESSURE, STROKE, AND CORONARY HEART-DISEASE .2. SHORT-TERM REDUCTIONS IN BLOOD-PRESSURE - OVERVIEW OF RANDOMIZED DRUG TRIALS IN THEIR EPIDEMIOLOGIC CONTEXT
    COLLINS, R
    PETO, R
    MACMAHON, S
    HEBERT, P
    FIEBACH, NH
    EBERLEIN, KA
    GODWIN, J
    QIZILBASH, N
    TAYLOR, JO
    HENNEKENS, CH
    [J]. LANCET, 1990, 335 (8693) : 827 - 838
  • [6] Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP)
    Cook, Nancy R.
    Cutler, Jeffrey A.
    Obarzanek, Eva
    Buring, Julie E.
    Rexrode, Kathryn M.
    Kumanyika, Shiriki K.
    Appel, Lawrence J.
    Whelton, Paul K.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2007, 334 (7599): : 885 - 888B
  • [7] DOMINICZAK A, 1988, J HUM HYPERTENS, V2, P53
  • [8] Lower progression rate of end-stage renal disease in patients with peripheral arterial disease using statins or angiotensin-converting enzyme inhibitors
    Feringa, Harm H. H.
    Karagiannis, Stefanos E.
    Chonchol, Michel
    Vidakovic, Radosav
    Noordzij, Peter G.
    Elhendy, Abdou
    van Domburg, Ron T.
    Welten, Gijs
    Schouten, Olaf
    Bax, Jeroen J.
    Berl, Tomas
    Poldermans, Don
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (06): : 1872 - 1879
  • [9] Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease
    Feringa, HHH
    van Waning, VH
    Bax, JJ
    Elhendy, A
    Boersma, E
    Schouten, O
    Galal, W
    Vidakovic, RV
    Tangelder, MJ
    Poldermans, D
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (06) : 1182 - 1187
  • [10] Rating the quality of evidence for clinical practice guidelines
    Hadorn, DC
    Baker, D
    Hodges, JS
    Hicks, N
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1996, 49 (07) : 749 - 754